Mainstream

Life biosciences announces research collaboration with singhealth duke nus regenerative medicine institute of singapore (remedis) to expand pipeline of cellular rejuvenation therapies

Life Biosciences Announces Research Collaboration with SingHealth Duke-NUS Regenerative Medicine Institute of Singapore (REMEDIS) to Expand Pipeline of Cellular Rejuvenation Therapies

Life Biosciences Announces Research Collaboration with SingHealth Duke-NUS Regenerative Medicine Institute of Singapore (REMEDIS) to Expand Pipeline of Cellular Rejuvenation Therapies

BOSTON, July 22, 2025 (GLOBE NEWSWIRE) — –

You might also be interested in reading Wisdomtree Expands Tokenized Funds to Solana, Boosting RWA Access.

July 22, 2025
In Mainstream